| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. | Chief Financial Officer | Share Option (Right to Buy) | 85,250 | 04 Feb 2026 | Direct | ||
| Quoin Pharmaceuticals, Ltd. | Chief Financial Officer | ADS | 440 | 18 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals, Ltd. | 04 Feb 2026 | 1 | $0 | 4 | Chief Financial Officer | 06 Feb 2026, 17:24 |
| QNRX | Quoin Pharmaceuticals, Ltd. | 01 Dec 2025 | 1 | $0 | 4 | Chief Financial Officer | 03 Dec 2025, 17:39 |
| QNRX | Quoin Pharmaceuticals, Ltd. | 18 Aug 2025 | 0 | $0 | 3 | CHIEF FINANCIAL OFFICER | 08 Sep 2025, 16:31 |